[go: up one dir, main page]

NO20031246D0 - Farmasöytisk blanding - Google Patents

Farmasöytisk blanding

Info

Publication number
NO20031246D0
NO20031246D0 NO20031246A NO20031246A NO20031246D0 NO 20031246 D0 NO20031246 D0 NO 20031246D0 NO 20031246 A NO20031246 A NO 20031246A NO 20031246 A NO20031246 A NO 20031246A NO 20031246 D0 NO20031246 D0 NO 20031246D0
Authority
NO
Norway
Prior art keywords
pharmaceutical blend
blend
pharmaceutical
Prior art date
Application number
NO20031246A
Other languages
English (en)
Other versions
NO20031246L (no
Inventor
Hiroshi Kikuchi
Michiko Iketani
Hideo Kobayashi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20031246D0 publication Critical patent/NO20031246D0/no
Publication of NO20031246L publication Critical patent/NO20031246L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20031246A 2000-09-19 2003-03-18 Farmasöytisk blanding NO20031246L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000283565 2000-09-19
PCT/JP2001/008137 WO2002024167A1 (fr) 2000-09-19 2001-09-19 Composition medicinale

Publications (2)

Publication Number Publication Date
NO20031246D0 true NO20031246D0 (no) 2003-03-18
NO20031246L NO20031246L (no) 2003-03-18

Family

ID=18767909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031246A NO20031246L (no) 2000-09-19 2003-03-18 Farmasöytisk blanding

Country Status (11)

Country Link
US (2) US20040022848A1 (no)
EP (1) EP1319399A1 (no)
JP (3) JPWO2002024167A1 (no)
KR (1) KR20030040389A (no)
CN (1) CN1247188C (no)
AU (1) AU2001290239A1 (no)
CA (1) CA2419434A1 (no)
NO (1) NO20031246L (no)
RU (1) RU2281757C2 (no)
TW (1) TWI290053B (no)
WO (1) WO2002024167A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
KR100712356B1 (ko) * 2003-01-23 2007-05-02 (주)아모레퍼시픽 서방성 제제 및 그의 제조방법
DE10323759A1 (de) * 2003-05-22 2004-12-16 Bauer, Wulf, Dr. Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen
JP4808392B2 (ja) * 2003-09-04 2011-11-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 苦味を隠蔽する薬理組成物
EP1825866A4 (en) * 2004-12-03 2008-03-12 Takeda Pharmaceutical SOLID PREPARATION
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PL2594272T3 (pl) * 2005-05-18 2018-11-30 Horizon Orphan Llc Fluorochinolony w aerozolu i ich zastosowania
US20070224323A1 (en) * 2006-03-23 2007-09-27 Fred Goldman Sugar Replacement and Baked Goods and Caramels Using the Sugar Replacement
PL2487161T5 (pl) 2007-02-23 2024-09-09 Gilead Sciences, Inc. <div>Modulatory właściwości farmakokinetycznych środków terapeutycznych</div><div> </div>
JP2011153075A (ja) * 2008-04-04 2011-08-11 Shionogi & Co Ltd 水懸濁性を向上させた細粒剤
PL2296633T3 (pl) 2008-05-02 2016-03-31 Gilead Sciences Inc Zastosowanie cząsteczek stałych nośników dla udoskonalenia przetwarzalności środka farmaceutycznego
WO2010042549A1 (en) 2008-10-07 2010-04-15 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
WO2010042553A1 (en) 2008-10-07 2010-04-15 Mpex Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
JP6180012B2 (ja) 2009-09-04 2017-08-16 ラプター ファーマスーティカルズ,インコーポレイテッド 嚢胞性線維症を治療するためのエアロゾル化レボフロキサシンの使用
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤
US10842802B2 (en) * 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
PT108978B (pt) * 2015-11-24 2020-03-09 Hovione Farm S A Sais de tetraciclinas
JP7672268B2 (ja) * 2020-04-22 2025-05-07 沢井製薬株式会社 コハク酸ソリフェナシン含有コーティング粒子及びそれを含む口腔内崩壊錠

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2915590B2 (ja) * 1991-02-15 1999-07-05 第一製薬株式会社 マスクされた粒状物
JP3130058B2 (ja) * 1991-02-15 2001-01-31 第一製薬株式会社 マスクされた粒状物
JP2915653B2 (ja) * 1991-11-14 1999-07-05 第一製薬株式会社 マスクされた粒状物
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
DE69432186T2 (de) * 1993-11-18 2004-05-06 Nippon Shinyaku Co., Ltd. Verfahren zur herstellung stabiler arzneimittel
ES2279519T3 (es) * 1995-05-02 2007-08-16 Taisho Pharmaceutical Co. Ltd Composicion para administracion por via oral.
JPH0995439A (ja) * 1995-09-29 1997-04-08 Eisai Co Ltd 固形製剤の製造方法
JP3126683B2 (ja) * 1996-04-16 2001-01-22 武田薬品工業株式会社 D−マンニトールおよびその製造法
KR20000005486A (ko) * 1996-04-16 2000-01-25 빌프리더 하이더 D-만니톨 및 그의 제법
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
BRPI9802144B1 (pt) * 1997-05-30 2017-03-28 Ezequiel Mayorga Jorge dispositivo osmótico multicapa aperfeiçoado
WO2000054811A1 (en) * 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
JP2001270821A (ja) * 2000-03-23 2001-10-02 Eisai Co Ltd 服用感が優れた散剤
JP2001302497A (ja) * 2000-04-21 2001-10-31 Eisai Co Ltd 混合性に優れた散剤

Also Published As

Publication number Publication date
RU2281757C2 (ru) 2006-08-20
HK1057474A1 (en) 2004-04-08
AU2001290239A1 (en) 2002-04-02
CN1455665A (zh) 2003-11-12
JP2012158610A (ja) 2012-08-23
JPWO2002024167A1 (ja) 2004-01-29
US20040022848A1 (en) 2004-02-05
NO20031246L (no) 2003-03-18
CN1247188C (zh) 2006-03-29
WO2002024167A1 (fr) 2002-03-28
KR20030040389A (ko) 2003-05-22
JP2014132022A (ja) 2014-07-17
EP1319399A1 (en) 2003-06-18
CA2419434A1 (en) 2003-02-07
TWI290053B (en) 2007-11-21
US20070196504A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
NO20071303L (no) Farmasoytiske preparater
DK1524266T3 (da) Farmaceutisk sammensætning
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
NO20033556D0 (no) Farmasöytiske preparater
NO20025450L (no) Ny farmasöytisk sammensetning
EP1329217A4 (en) Solid preparations
NO20031097L (no) Kinolinderivater
ITTO20010005A1 (it) Formulazione farmaceutica.
ITMI20010748A0 (it) Composizioni farmaceutiche
IS6040A (is) Valdekoxib efnablöndur
ID29089A (id) Sediaan farmasi moksifloksasin
EE200300416A (et) Ravimvorm
DE50114386D1 (de) Ng
EE200200150A (et) Preparaat
DK1466615T3 (da) Farmaceutisk præparat
NO20031246L (no) Farmasöytisk blanding
NO20030276D0 (no) Fremgangsmåte
NO20022606L (no) Farmasöytiske kombinasjoner
NO20026123L (no) Farmasöytiske sammensetninger
NO20031095L (no) Farmasoytiske sammensetninger
IS6163A (is) Lyfjakomplex
DE60143209D1 (de) Zweiport-demodulationseinrichtung
DE50009295D1 (de) Vernetzerfreie zubereitungen
EE200200689A (et) Ravimkoostised
ATE252549T1 (de) Aminobutyronitril mischung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application